Welcome to LookChem.com Sign In|Join Free
  • or
The chemical compound "[5α,7α]-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3,6-dimethoxy-α,17-dimethyl-6,14-ethenomorphinan-7-methanol" is a complex organic molecule belonging to the morphinan class. It features a 7-methanol functional group, an epoxy group at the 4,5 positions, and a double bond between carbons 6 and 14. The molecule also contains two methyl groups at the 3 and 17 positions, and two methoxy groups at the 3 and 6 positions. The 1,1-dimethylethyl group is attached to the alpha carbon, and the compound has a dihydro structure at the 18,19 positions. This specific arrangement of functional groups and atoms gives the compound its unique properties and potential applications in various fields, such as pharmaceuticals or chemical research.

22152-80-3

Post Buying Request

22152-80-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

22152-80-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 22152-80-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,1,5 and 2 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 22152-80:
(7*2)+(6*2)+(5*1)+(4*5)+(3*2)+(2*8)+(1*0)=73
73 % 10 = 3
So 22152-80-3 is a valid CAS Registry Number.

22152-80-3Relevant academic research and scientific papers

PROCESS FOR THE SYNTHESIS OF BUPRENORPHINE

-

, (2021/08/06)

The present invention relates to a novel route of synthesis for the opioid receptor antagonist Buprenorphine or a pharmaceutically acceptable salt thereof, starting from thebaine, wherein the route comprises the reaction of the baine with a dienophile; forming an alkylated reaction product by reaction with a Grignard-reagent; formation of an cyanamide; deprotection of the cyanamide- and the phenolic-oxygen-moiety, wherein the cleavage of one or both groups is performed in the presence of an alkali or alkaline earth sulfide; followed by derivatization with a cyclopropyl-halogen and hydrogenation to yield Buprenorphine.

DEUTERATED COMPOUND AND MEDICAL USE THEREOF

-

Paragraph 0019, (2020/01/12)

The present invention relates to a compound represented by formula I and a non-toxic pharmaceutically acceptable salt thereof. In formula (I), R1 is H, CH3 or deuterated methyl (CD3); R2 is CH3 or CH2CH3; R3, R4 and R5 are each independently H or deuterium (D); when R1 is H or CH3, at least one of R3, R4 and R5 is D.

PROCESS FOR THE PREPARATION OF (S)-2-((4R,4AS, 6R,7AR,12BS)-7,9-DIMETHOXY-1,2,3,4,5,6,7,7A-OCTAHYDRO-4A,7-ETHANO-4, 12-METHANOBENZOFURO[3,2-E] ISOQUINOLIN-6-YL)-3,3-DIMETHYLBUTAN-2-OL

-

, (2017/05/02)

An invention includes a process for the preparation of (S)-2((4R,4aS,6R,7R,7aR,12bS)-7,9-dimethoxy-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-6-yl)-3,3-dimethylbutan-2-ol.

PROCESS FOR THE PREPARATION OF OPIOID COMPOUNDS

-

, (2015/11/27)

The present invention is directed to a process for the preparation of opioid compounds such as buprenorphine, naltrexone, naloxone, nalbuphone, nalbuphine, and the like.

Industrial process for the preparation of buprenorphine and its intermediates

-

, (2015/01/18)

There is provided an efficient industrial process for the preparation of 21-cyclopropyl-7a-(2-hydroxy-3,3-dimethyl-2-butyl)-6,14-endo-ethano-6,7,8,14-tetrahydro-oripavine,i.e. buprenorphine of Formula- I in high yield and purity, with enhanced safety and eco-friendly norms. The invention further relates to an improved process for preparation of intermediates thereof in high yield and purity.

INDUSTRIAL PROCESS FOR THE PREPARATION OF BUPRENORPHINE AND ITS INTERMEDIATES

-

, (2015/01/06)

There is provided an efficient industrial process for the preparation of 21-cyclopropyl-7α-(2-hydroxy-3,3-dimethyl-2-butyl)-6,14-endo-ethano-6,7,8,14-tetrahydro-oripavine, i.e. buprenorphine of Formula-I in high yield and purity, with enhanced safety and eco-friendly norms. The invention further relates to an improved process for preparation of intermediates thereof in high yield and purity.

PROCESSES FOR THE PRODUCTION OF BUPRENORPHINE WITH REDUCED IMPURITY FORMATION

-

Page/Page column 26-28, (2010/04/27)

The present invention provides process for the production of opiate alkaloids. In particular, the present invention provides processes for the production of buprenorphine or a derivative of buprenorphine that minimizes the formation of impurities.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 22152-80-3